Yasin DALDA, Emrah SAHIN, Koray KUTLUTÜRK

Meme cerrahisinde re-eksizyon gerektiren vakalar için basit bir öneri'

Meme kanseri özellikle kadınları etkileyen önemli bir sağlık sorunudur. Cerrahi prosedürlerin birincil tedavi yöntemi olduğu meme kanserinde, radyoterapi ile birlikte meme koruyucu cerrahi, mastektomiden daha popüler hale gelmektedir. Nüks veya pozitif cerrahi sınır durumlarında yeniden eksizyon gerekebilir. Eski ameliyat lojunda skar oluşumu nedeniyle oluşan kavitenin hasar görmesi diseksiyonu zorlaştırabilir. Diseksiyon planının net olarak görülememesi eksik cerrahi veya fazla doku çıkarılması ile sonuçlanabilir. Meme kanseri nedeniyle meme koruyucu cerrahi geçiren ve nüks şüphesiyle başvuran bir hastada ameliyat sırasında uyguladığımız basit bir teknikle lezyonu makroskopik olarak net sınırlarla nasıl çıkardığımızı sunuyoruz.

Anahtar Kelimeler:

meme kanseri, meme koruma cerrahisi, rekürrens

Simple recommendation for cases requiring re-excision on breast surgery

Breast cancer is an important health problem that especially affects women. In breast cancer where surgical procedures are the primary treatment modality, breast-conserving surgery with radiotherapy is becoming more popular than mastectomy. Re-excision may be necessary in cases of recurrence or positive surgical margins. Damage to the cavity formed due to scar formation in the old operation lodge may make dissection difficult. Failure to see the dissection plan clearly may result in incomplete surgery or removal of excess tissue. We present how we macroscopically removed the lesion with clear margins with a simple technique we performed during surgery in a patient who underwent breast-conserving surgery for breast cancer and presented with suspicion of recurrence.

Keywords:

Breast cancer, breast-conserving surgery, recurrence,

PDF

___

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33.
Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718.
Jonczyk MM, Jean J, Graham R, Chatterjee A. Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis. Breast Cancer Res Treat. 2019;173:267–74.
Bertozzi N, Pesce M, Santi PL, Raposio E. Oncoplastic breast surgery: comprehensive review. Eur Rev Med Pharmacol Sci. 2017;21:2572–85.
Ulucanlar H, Ağaç A, Kutun S, Demir A, Yükrük FA, Çetin A. Fibröz kapsülle çevrili ve cerrahi rezeksiyon gerektiren seroma olgusu: olgu sunumu. Balkan Med J. 2008;2008:169–72.
Kaufmann M, Morrow M, Von Minckwitz G, Harris JR. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer. 2010;116:1184–91.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.
Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88:553–64.
Houssami N, Macaskill P, Luke Marinovich M, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30.
Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys. 2005;63:845–51.